The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...
Check out my animated remake of BFDI where everything is flipped into opposites see how your favorite characters change in this fun twist #BFDI #AnimatedStory #OppositeBFDI #AnimationFun ...
The German data protection authority (BfDI) has fined Vodafone GmbH, the telecommunications company's German subsidiary, €45 million ($51.4 million) for privacy and security violations. "Due to ...
All the Latest Game Footage and Images from BFDI: Branches BFDI: Branches is an all-new platformer game with Firey, Leafy, Coiny, and Pin! Featuring multiple characters with varied gameplay, a story ...
Kushagra is a dedicated List Writer at Gamerant, a leading platform in the gaming industry. With a passion for video games and a keen eye for detail they can craft engaging and informative articles ...
Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW. This is an ...
Amivantamab plus lazertinib vs osimertinib in first-line EGFR-mutant advanced non-small cell lung cancer (NSCLC) with biomarkers of high-risk disease: A secondary analysis from the phase 3 MARIPOSA ...
Antibody-mediated rejection is a leading cause of kidney-transplant failure. The targeting of CD38 to inhibit graft injury caused by alloantibodies and natural killer (NK) cells may be a therapeutic ...
When a randomized evaluation finds null results, it is important to understand why. We investigated two very different explanations for the finding from a randomized evaluation that the Camden ...
The concept of randomized generalized second-price (RGSP) auctions sent shockwaves through the PPC community after the subject took center stage at the Google antitrust trial. While some digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results